glp-1 medications approved for type 2 diabetes 2025 How Employers Can Optimize Benefits in the Era of GLP-1s GLP-1 Drugs and Type 1

elegans , elevated GLP-1/Notch activity promotes the formation of germline tumors (Berry et al., 1997)

Mechanism specificity GLP-1 agonists have a defined, targeted mechanism

The company has reformulated the drug to improve tolerability, reflecting the industry's broader effort to develop more patient-friendly alternatives to injectable therapies

Other mouse models have been derived in an attempt to separate the role of -cell glucagon and GLP-1

The care model is intentionally streamlined: onboarding takes minutes, prescriptions are processed quickly, auto-refills are built in, and dose adjustments follow a simple escalation pathway

These agents enhance glucose-dependent insulin secretion from pancreatic beta cells, suppress inappropriate glucagon release, slow gastric emptying, and act on central nervous system appetite centers to promote satiety